Friday, August 1, 2025

Chesterfield medical devices provider secures investment from private equity firm

TalarMade, a provider of medical devices and clinical services, has secured a strategic investment from private equity firm Rockpool.

With Rockpool’s backing, TalarMade will accelerate its expansion plans, enhance innovation across product lines, and continue delivering high-quality, evidence-based solutions to healthcare professionals and patients across the UK.

TalarMade, founded by chairman Bernie Crewdson in 2002 and led by CEO Ryan Thomas, specialises in orthotics and pressure care products, serving both NHS and private sector healthcare providers.

Rockpool is investing alongside the existing management team and is backing TalarMade’s expansion plans with new growth capital.

Ryan Thomas, CEO of TalarMade, said: “Rockpool’s investment is a strong vote of confidence in our strategy, people, and future. With their backing, we’ll accelerate our growth and continue delivering innovative, evidence-based products.

“Our leadership team and core values remain unchanged, ensuring continuity for our staff and distribution partners with a commitment to deliver the same high standards our customers expect.”

Bernie Crewdson, founder & chairman of TalarMade, added: “I am excited for the opportunities ahead of TalarMade. The injection of investment and support from Rockpool will enable the team to accelerate the growth of the business I founded over 20 years ago. I have confidence in Ryan and the leadership team to continue my legacy and look forward to sharing in the success.”

Tom Coey, partner at Rockpool, said: “TalarMade’s reputation for clinical excellence and product innovation makes it a standout business in the UK healthcare market. We look forward to supporting Ryan and his team as TalarMade expands into new geographies, pursues strategic acquisitions, and continues to deliver high-quality, evidence-based products for healthcare professionals and patients alike.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.












Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close